(Reuters) -Elon Musk's brain implant company Neuralink aims to generate at least $1 billion in annual revenue by 2031, driven by plans to perform 20,000 surgeries per year, Bloomberg News reported on Wednesday, citing investor documents.

The company aims to operate five large clinics within six years and offer three versions of its brain device, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report.

Neuralink did not immediately respond to a Reuters request for comment.

The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)